Alchemab Therapeutics
Olivia Snudden is an experienced professional in the life sciences sector, currently serving as an Associate Project Manager at Alchemab Therapeutics Ltd since March 2021, with prior roles as a Scientist, Associate Scientist, and Laboratory Assistant. Before joining Alchemab, Olivia worked as a PCR Scientist at the COVID-19 Cambridge Testing Centre, where responsibilities included preparing samples, conducting RT-PCR reactions, and adhering to SOPs in a BSL2 laboratory. A Summer Intern at Cresset Software and Discovery Services in 2018, Olivia utilized Python to assess computational needs for product workflows and engaged in marketing analysis. Olivia holds a BSc in Biochemistry with Management from Imperial College London, completed in 2020, and graduated from St Benedict's Catholic School in 2016.
Alchemab Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.